Skip to main content
Top
Published in: Trials 1/2024

Open Access 01-12-2024 | Antibiotic | Study protocol

Efficacy of amoxicillin/clavulanic acid after surgical drainage of perianal abscess in the prevention of the development of anal fistula (PERIQxA study): study protocol for a multicenter randomized, double-blind clinical trial

Authors: Verónica Polaino Moreno, Antonio F. Caballero-Bermejo, Mariano Artés Caselles, Javier Serrano González, Xabier Remírez Arriaga, Natalia González Alcolea, Aritz Equisoain Azcona, Eva Iglesias García, José Luis Lucena de la Poza, Arsenio Sánchez Movilla, Belén Ruiz-Antorán, PERIQxA Study Group

Published in: Trials | Issue 1/2024

Login to get access

Abstract

Background

Anorectal fistula, which is a relatively common pathology, is the chronic manifestation of the acute perirectal process that forms an anal abscess. The development of a fistula after incision and drainage of an anal abscess is seen in approximately 26–37%. Its treatment is a relevant topic, and the role of the use of antibiotic therapy in its prevention remains controversial, after the publication of several studies with contradictory results and several methodological limitations. Our hypothesis is that the combination of amoxicillin and clavulanic acid will reduce the incidence of anal fistula.

Method

The aim of this study is to evaluate the efficacy of antibiotherapy after surgical drainage of perianal abscess in the development of perianal fistula. The PERIQxA study is a multicenter, randomized, double-blind controlled trial. The study has been designed to include 286 adult patients who will be randomly (1:1) assigned to either the experimental (amoxicillin/clavulanic acid 875/125 mg TDS for 7 days) or the control arm (placebo). The primary outcome measure is the percentage of patients that develop perianal fistula after surgery and during follow-up (6 months).

Discussion

This clinical trial is designed to evaluate the efficacy and safety of amoxicillin/clavulanic in the prevention of perianal fistula. The results of this study are expected to contribute to stablish the potential role of antibiotherapy in the therapeutics for anal abscess.

Trial registration

EudraCT Number: 2021–003376-14. Registered on November 26, 2021.
Appendix
Available only for authorised users
Literature
6.
Metadata
Title
Efficacy of amoxicillin/clavulanic acid after surgical drainage of perianal abscess in the prevention of the development of anal fistula (PERIQxA study): study protocol for a multicenter randomized, double-blind clinical trial
Authors
Verónica Polaino Moreno
Antonio F. Caballero-Bermejo
Mariano Artés Caselles
Javier Serrano González
Xabier Remírez Arriaga
Natalia González Alcolea
Aritz Equisoain Azcona
Eva Iglesias García
José Luis Lucena de la Poza
Arsenio Sánchez Movilla
Belén Ruiz-Antorán
PERIQxA Study Group
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Trials / Issue 1/2024
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-024-07922-3

Other articles of this Issue 1/2024

Trials 1/2024 Go to the issue